283 related articles for article (PubMed ID: 31018848)
1. Bisphosphonate combination therapy for non-femoral avascular necrosis.
Agarwala S; Vijayvargiya M
J Orthop Surg Res; 2019 Apr; 14(1):112. PubMed ID: 31018848
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate Combination Therapy in the Management of Postchemotherapy Avascular Necrosis of the Femoral Head in Adolescents and Young Adults: A Retrospective Study From India.
Agarwala S; Banavali SD; Vijayvargiya M
J Glob Oncol; 2018 Sep; 4():1-11. PubMed ID: 30241233
[TBL] [Abstract][Full Text] [Related]
3. Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.
Kraenzlin ME; Graf C; Meier C; Kraenzlin C; Friedrich NF
Knee Surg Sports Traumatol Arthrosc; 2010 Dec; 18(12):1638-44. PubMed ID: 20376625
[TBL] [Abstract][Full Text] [Related]
4. A Paradigm Shift in Osteonecrosis Treatment with Bisphosphonates: A 20-Year Study.
D Orth SA; Vijayvargiya M
JB JS Open Access; 2021; 6(4):. PubMed ID: 34934885
[TBL] [Abstract][Full Text] [Related]
5. Does alendronate prevent collapse in osteonecrosis of the femoral head?
Nishii T; Sugano N; Miki H; Hashimoto J; Yoshikawa H
Clin Orthop Relat Res; 2006 Feb; 443():273-9. PubMed ID: 16462451
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates for Post-COVID Osteonecrosis of the Femoral Head: Medical Management of a Surgical Condition.
Agarwala S; Vijayvargiya M; Sawant T; Kulkarni S
JB JS Open Access; 2022; 7(4):. PubMed ID: 36420354
[TBL] [Abstract][Full Text] [Related]
7. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study.
Lai KA; Shen WJ; Yang CY; Shao CJ; Hsu JT; Lin RM
J Bone Joint Surg Am; 2005 Oct; 87(10):2155-9. PubMed ID: 16203877
[TBL] [Abstract][Full Text] [Related]
8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label study.
Agarwala S; Jain D; Joshi VR; Sule A
Rheumatology (Oxford); 2005 Mar; 44(3):352-9. PubMed ID: 15572396
[TBL] [Abstract][Full Text] [Related]
10. The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years.
Agarwala S; Shah S; Joshi VR
J Bone Joint Surg Br; 2009 Aug; 91(8):1013-8. PubMed ID: 19651826
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: a retrospective comparative study with alendronate.
Arai R; Takahashi D; Inoue M; Irie T; Asano T; Konno T; Terkawi MA; Onodera T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Jan; 18(1):24. PubMed ID: 28103867
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Sánchez A; Blanco R
Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
[TBL] [Abstract][Full Text] [Related]
13. Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.
Tian Y; Wang R; Liu L; Ma C; Lu Q; Yin F
BMC Musculoskelet Disord; 2016 Feb; 17():72. PubMed ID: 26867651
[TBL] [Abstract][Full Text] [Related]
14. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF
Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052
[TBL] [Abstract][Full Text] [Related]
15. Evidence for using alendronate to treat adult avascular necrosis of the femoral head: a systematic review.
Luo RB; Lin T; Zhong HM; Yan SG; Wang JA
Med Sci Monit; 2014 Nov; 20():2439-47. PubMed ID: 25424061
[TBL] [Abstract][Full Text] [Related]
16. Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.
Jäger M; Tillmann FP; Thornhill TS; Mahmoudi M; Blondin D; Hetzel GR; Zilkens C; Krauspe R
Arthritis Res Ther; 2008; 10(5):R120. PubMed ID: 18834533
[TBL] [Abstract][Full Text] [Related]
17. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices.
Fugazzotto PA; Lightfoot WS; Jaffin R; Kumar A
J Periodontol; 2007 Sep; 78(9):1664-9. PubMed ID: 17760533
[TBL] [Abstract][Full Text] [Related]
18. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
[TBL] [Abstract][Full Text] [Related]
19. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
20. Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic.
Craig SJ; Youssef PP; Vaile JH; Sullivan L; Bleasel JF
Intern Med J; 2011 Feb; 41(2):186-90. PubMed ID: 20214696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
